Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P240036/S007

OmniaSecure MRI SureScan Lead Model 3930M

Medtronic, Inc. · Decision date Oct 23, 2026

MEDTECHLEDGER EXPLANATIONP240036/S007

What did the FDA decide?

The FDA record P240036/S007 concerns the OmniaSecure MRI SureScan Lead Model 3930M, listed under permanent defibrillator electrodes in the cardiovascular specialty, with Medtronic, Inc. as applicant. The supplement is a 30-Day Notice, and its reason field is a process change covering manufacturer, sterilizer, packager or supplier. Its stated purpose is to add an additional in-process inspection during the manufacturing of the OmniaSecure leads.

Indexed under PMA P240036, this filing amends manufacturing for the referenced lead rather than constituting a new approval of the whole system. The record does not identify the inspection step, the manufacturing stage it follows, acceptance criteria, or supporting data, and the stated purpose does not by itself establish safety or clinical effectiveness.

The date on the record is 2026-10-23 and the decision entry reads OK30.

FDA approval order statement

to add an additional in-process inspection during the manufacturing of the OmniaSecure leads
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Oct 23, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P240036/S007
Regulatory pathway
PMA supplement
Product code
NVY
Decision code
OK30
Decision date
Oct 23, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Permanent defibrillator electrodes.

Product code
NVY
FDA device class
3

For the original device and its historical approval scope, see PMA P240036. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P240036 · Original PMA

    OmniaSecure MRI SureScan Lead Model 3930M

  2. P240036/S007 received

    Application receipt date recorded by FDA.

  3. P240036/S007 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P240036. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P240036

Product / regulatory recordCompanyPathwayDecision dateSource
Medtronic, Inc.PMA approvalApr 22, 2025FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic, Inc.

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
8200 Coral Sea St. N.E, Mounds View, MN, 55112

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records